UW Medicine 16th Annual Comprehensive Hematology & Oncology Review Course 2025

1. Overview

The UW Medicine 16th Annual Comprehensive Hematology & Oncology Review Course 2025 delivers an extensive update on the standard of care for blood disorders and malignancies. This course synthesizes the latest clinical data, treatment guidelines, and therapeutic advances to optimize patient management in both hematology and oncology practice.

Monday, October 6, 2025, 7:00 AM – Friday, October 10, 2025, 5:00 PM, Other, Seattle, WA

2. Learning Objectives

• Evaluate recent advances in the management of acute and chronic leukemias, lymphomas, and multiple myeloma.

• Apply updated treatment algorithms for solid tumors including breast, lung, GI, GU, and gynecologic cancers.

• Integrate new pharmacological agents and immunotherapies into clinical practice for better patient outcomes.

• Identify and manage complications of cancer treatments, including thrombosis and infectious diseases.

• Discuss evolving strategies in supportive care, transfusion medicine, and hematopoietic cell transplantation.

3. Target Audience

Best for hematologists and oncologists who want comprehensive updates on diagnosing and treating blood disorders and solid tumors.

4. Topics

• Acute Lymphoblastic Leukemia

• Acute Myeloid Leukemia

• Adjuvant Therapy for Breast Cancer

• Anal Cancer

• Benign White Cell Disorders

• Bladder Cancer

• Bleeding Disorders

• B-NHL, Aggressive Non-Hodgkin Lymphoma

• B-NHL, Indolent Non-Hodgkin Lymphoma

• Cholangiocarcinoma

• Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) & Hairy Cell Leukemia

• Chronic Myeloid Leukemia

• CNS Cancers

• Colorectal Cancer

• Consultative Hematology

• Esophageal-Gastric Cancer

• Familial Syndromes

• Gastrointestinal Neuroendocrine Tumors

• Gynecologic Oncology – Cervical and Endometrial Cancers

• Gynecologic Oncology – Ovarian Cancer

• Head, Neck and Thyroid Cancer

• Hematology Pharmacology Pearls

• Hematopoietic Cell Transplantation

• Hepatocellular Cancer

• Hodgkin Lymphoma

• Infectious Disease Complications

• Inherited & Acquired Marrow Failure

• Integrative Medicine

• Iron Metabolism Disorders & Hemolytic Anemias

• Melanoma and Other Skin Cancers

• Mesothelioma

• Metastatic Breast Cancer

• Myelodysplastic Syndromes

• Myeloproliferative Neoplasms

• Newly-Diagnosed Myeloma

• Non-Small Cell Lung Cancer – Adjuvant-Locally Advanced

• Non-Small Cell Lung Cancer – Metastatic

• Pancreatic Cancer

• Prostate Cancer

• Radiation Oncology – Multi-Disciplinary [Breast, Lung, Colorectal, and Palliative]

• Relapsed-Refractory Myeloma & Amyloidosis

• Renal Cell Carcinoma

• Sarcoma

• Small Cell Lung Cancer

• Smoldering Myeloma & MGUS

• Solid Tumor Pharmacology Pearls

• Supportive Care

• T-Cell Lymphoma – NHL

• Testicular Cancer

• Thalassemia & Hemoglobinopathies

• Therapy for Non-Invasive Breast Cancer

• Thrombocytopenia

• Thrombosis & Anticoagulation

• Transfusion Medicine